VIR · Vir Biotechnology, Inc.

$8.65 -0.20 (-2.26%) At close · Jul 29

Market Cap

$1.49B

168.65M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne De Backer	CEO	$950,000	—	$2,296,800	$3,507,360	$1,002,750	$77,135	$7,834,045
Mark Eisner	Chief Medical Officer	$660,833	$375,000	$382,800	$584,560	$354,291	$14,000	$2,371,484
Jason O’Byrne	CFO	$534,417	$150,000	$382,800	$584,560	$286,051	$14,000	$1,951,828
Vanina de Verneuil	General Counsel	$506,333	—	$334,950	$511,490	$329,648	$8,363	$1,690,784

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne De Backer	CEO	$920,833	$2,500,000	$1,769,250	$2,697,800	$1,021,200	$346,820	$9,255,903
Mark Eisner	CTO	$379,167	$375,000	$702,750	$1,075,095	$221,130	$3,123	$2,756,265
Jason O’Byrne	CFO	$130,492	$150,000	$648,000	$991,335	—	—	$1,919,827
Sung Lee	CFO	$184,527	$500,000	$404,400	$616,640	—	$33,990	$1,739,557
Vanina de Verneuil	General Counsel	$486,667	$300,000	$227,475	$346,860	$296,352	$12,117	$1,669,471

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Marianne De Backer	CEO	$675,000	$2,500,000	$13,419,803	$21,604,153	$855,360	$437,179	$39,491,495
Sung Lee	CFO	$402,865	—	$1,530,165	$2,472,231	$293,423	$149,690	$4,848,374
Jeffrey Calcagno	Executive Vice President and Chief Business Officer	$314,394	$400,000	$1,410,200	$2,269,432	$146,100	—	$4,540,126
Johanna Friedl-Naderer	COO	$604,640	—	$1,620,600	$1,533,616	$273,843	$196,964	$4,395,064
Phillip Pang	CTO	$527,000	—	$1,620,600	$1,533,616	$257,774	$13,200	$3,952,190
Steven Rice	Chief Administrative Officer Herbert (“Skip”) Virgin, M.D., Ph.D.	$281,265	—	$1,971,730	$1,007,805	—	—	$3,260,800
Howard Horn	CFO	$159,167	—	—	—	—	$442,133	$601,300
George Scangos	CEO	$325,000	—	—	—	—	$13,200	$338,200

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	CEO	$638,333	—	$2,489,730	$4,043,885	$295,750	$12,200	$7,479,898
Johanna Friedl-Naderer	COO	$444,396	$1,100,000	$2,171,700	$907,412	$202,230	$86,416	$5,040,031
Phillip Pang	CTO	$507,400	$125,000	$1,975,160	$1,578,694	$192,780	$12,200	$4,391,234
Howard Horn	CFO	$475,167	—	$1,031,800	$1,233,355	$150,413	$12,200	$2,902,935
Steven Rice	Chief Administrative Officer Herbert (“Skip”) Virgin, M.D., Ph.D.	$485,633	—	$589,600	$986,684	$184,464	—	$2,246,381

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	CEO	$575,000	—	$7,479,180	$12,129,858	$487,000	$11,600	$20,682,838
Phillip Pang	CTO	$492,000	—	$2,156,160	$3,496,896	$276,864	$11,600	$6,433,520
Howard Horn	CFO	$461,250	—	$1,684,500	$2,731,950	$259,560	$11,600	$5,148,860
Steven Rice	Chief Administrative Officer Herbert (“Skip”) Virgin, M.D., Ph.D.	$471,500	—	$1,347,600	$2,185,560	$265,328	—	$4,269,988

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Steven Rice	Chief Administrative Officer Herbert (“Skip”) Virgin, M.D., Ph.D.	$441,667	—	—	$1,476,236	$256,956	—	$2,174,859
Howard Horn	CFO	$444,333	—	—	$960,186	$226,100	$11,400	$1,642,019
George Scangos	CEO	$544,583	—	—	—	$438,900	$11,400	$994,883
Michael Kamarck	CTO	$426,400	—	—	—	$266,000	$111,400	$803,800

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	CEO	$514,583	—	—	$3,158,780	$260,044	$11,200	$3,944,607
Howard Horn	CFO	$413,333	—	—	$1,614,687	$174,720	$11,200	$2,213,940

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
George Scangos	CEO	$512,019	—	—	—	$260,000	$11,000	$783,019

Executive changes

Person	Role	Change	Effective	Filed
Brent Sabatini	interim "principal financial officer"	Appointed	2026-08-03	2026-07-24
Jason O'Byrne	Executive Vice President and Chief Financial Officer	Resigned	2026-08-03	2026-07-24
Timothy Coughlin	Chair of the Audit Committee of the Board	Appointed	2026-06-09	2026-06-10
Timothy Coughlin	Class III director	Appointed	2026-06-09	2026-06-10
Saira Ramasastry, M.S., M.Phil.	Chair of the Company's Audit Committee	Resigned	2026-05-26	2026-05-28
Marianne De Backer, M.Sc., Ph.D., MBA	President	Appointed	2026-03-04	2026-03-04

Key facts CIK 1706431 CUSIP 92764N102 13F (30d) 38 filings 38 filers Visit website Investor relations